Literature DB >> 7465784

Relationship between surviving fractions using the colony methods, the LD50, and the growth delay after irradiation of human melanoma cells grown as multicellular spheroids.

N Pourreau-Schneider, E P Malaise.   

Abstract

Entities:  

Mesh:

Year:  1981        PMID: 7465784

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


× No keyword cloud information.
  7 in total

Review 1.  Multicellular spheroids. A review on cellular aggregates in cancer research.

Authors:  W Mueller-Klieser
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

2.  Clonogenicity of mammalian cells in hybrid spheroids: a new assay method.

Authors:  B Djordjevic; C S Lange
Journal:  Radiat Environ Biophys       Date:  1990       Impact factor: 1.925

3.  Growth and radiation sensitivity of the MLS human ovarian carcinoma cell line grown as multicellular spheroids and xenografted tumours.

Authors:  E K Rofstad; R M Sutherland
Journal:  Br J Cancer       Date:  1989-01       Impact factor: 7.640

4.  The radiation response of V79 and human tumour multicellular spheroids--cell survival and growth delay studies.

Authors:  C M West; R R Sandhu; I J Stratford
Journal:  Br J Cancer       Date:  1984-08       Impact factor: 7.640

5.  131I-meta-iodobenzylguanidine therapy in neuroblastoma spheroids of different sizes.

Authors:  M N Gaze; R J Mairs; S M Boyack; T E Wheldon; A Barrett
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

6.  Deriving cell survival curves from the overall responses of irradiated tumours: analysis of published data for tumour spheroids.

Authors:  J V Moore; C M West; J H Hendry
Journal:  Br J Cancer       Date:  1987-09       Impact factor: 7.640

7.  In vitro cytotoxic drug sensitivity testing of human tumour xenografts grown as multicellular tumour spheroids.

Authors:  A C Jones; I J Stratford; P A Wilson; M J Peckham
Journal:  Br J Cancer       Date:  1982-12       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.